O02 – 68Ga-DOTATATE PET/CT Imaging for Advanced Neuroendocrine Carcinoma in the United States

Published in 2011 Listed under Other

Eric H. Liu, Jeff Clanton, Dominique Delbeke, Martin Sandler, Bill Martin, Ronald C. Walker

O03 – Open-Label Phase 2 Clinical Trial of LX1606 / LX1032 in Europe: A Novel Agent for Reducing Serotonin Production in Carcinoid Syndrome

Published in 2010 Listed under Other

Phil Brown, Kenny Frazier, Jessica Jackson, Shanna Jackson, Joel Frieman, Brian Zambrowicz

O07 – Tumor and Normal Tissue Uptake of 68Ga-DOTA-tyr3- Octreotide after Treatment with Unlabeled Octreotide in Patients with Carcinoid Tumors and Pancreatic Neuroendocrine Tumors

Published in 2010 Listed under Other

Yusuf Menda, MD, Michael Schultz, PhD, David Bushnell, MD, Thomas O’Dorisio, MD, M. Sue O’Dorisio, MD, PhD